`RESEARCH
`
`
`
`APPLICATION NUMBER:
`
`214324Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`
`
`MEMORANDUM
`
`DATE:
`
`May 22, 2022
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`TO:
`
`FROM:
`
`Administrative file for NDA 214324
`
`Brian Cooney, Regulatory Health Project Manager
`Division of Cardiology and Nephrology, Office of Cardiology, Hematology,
`Endocrinology and Nephrology
`
`SUBJECT: Officer/Employee List for NDA 214324
`
`APPLICATION/DRUG:
`
`NDA 214324, Tyvaso DPI (treprostinil) inhalation powder
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Adams, Grafton
`Caruth, Brian
`Chi, Xuan
`Childers, Alexis
`Cooney, Brian
`Foss, David
`Fromm, Edward J
`Gontcharov, Alexander
`Griffiths, LaShawn
`Jansen, Daniel
`Kane, Bridget
`Khairuzzaman, Akm
`Mayrosh, Ruth
`Mehta, Hina
`Monteleone, Michael V.
`Oguntimein, Oluwamurewa
`Psotka, Mitchell
`Sapru, Mohan
`Senatore, Fortunato
`Southworth, Mary R.
`Stockbridge, Norman L
`Walker, Morgan
`Xu, Xiaomeng
`Yang, Baichun
`
`Reference ID: 4987718
`
`
`
`Signature Page 1 of 1
`--------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically. Following this are manifestations of any and all
`electronic signatures for this electronic record.
`--------------------------------------------------------------------------------------------
`/s/
`------------------------------------------------------------
`
`BRIAN T COONEY
`05/22/2022 02:52:16 PM
`
`Reference ID: 4987718
`
`(
`
`
`
`